If you reverse your thesis it works This is how YOU WILL LOSE A MILLION DOLLARS OR MORE take $1000000 and buy millions of shares and in 1 yr it`ll be worth 0.0001
you should have waited I bought 1m for half the price you paid maybe you should buy another 10m neom is having a 50% off sale at the mall
December 4, 2012
Graphite One Resources (GPH.V) announced their maiden resource estimate on their Graphite Creek Project in Alaska.
They easily surpassed our estimate of 75M tonnes we were talking about in our previous blog post, as they outlined a resource estimate of 107M tonnes at an average grade of almost 5.8%Cg based on a cut-off grade of 3% Cg. If we apply a higher cut-off grade of 7% Cg, Graphite Creek contains in excess of 25M tonnes at an average grade of 9.7%Cg.
This resource estimate is much better than expected, and we are looking forward to their future drill campaigns as we now have an official exploration target of up to almost half a billion tonnes.
Graphite One expects to update the market with a PEA in the summer of 2013, and then we will be able to compare their economics to other graphite projects. 2013 should be a very exciting year for Graphite One.
We first talked about Graphite One (GPH.V) in November when the share price was trading at C$0.13. Since our first blog post the company has made tremendous progress and released an excellent NI43-compliant resource estimate on their 100% owned Graphite Creek project containing almost 165 million tonnes at 4.61%Cg. This is just a first step as the company confirmed an exploration target of 235 – 495 million tonnes.
Graphite One was able to raise C$600,000 at C$0.14 on the back of this resource estimate which is is good as a lot of junior explorers are struggling to survive at this moment.
GPH has a serious advantage over its competitors in the graphite space as they are one of the very few graphite companies in the USA, and are located on the western side of the continent which makes them the preferred supplier for the Asian market as the shipping costs from Alaska to Asia will be much lower than the cost for potential graphite producers in Québec.
The new plan would provide 6% of K-V's new common stock to convertible noteholders that aren't part of the investment group and the right to participate in a rights offering for 30% of the company's equity, worth $85 million. The investor group would backstop the offering, meaning they would purchase any unsold shares.
By Stephanie Gleason
K-V Pharmaceutical Co. (KVPBQ, KVPHQ) is pursuing an alternative bankruptcy-exit plan funded by a group of convertible noteholders that has agreed to invest up to $250 million in exchange for majority ownership of the pharmaceutical company.
The investor group--which includes funds controlled by Greywolf Capital, Capital Venture International, Deutsche Bank Securities Inc. and Kingdon Associates--has agreed to invest $165 million and buy any shares that go unsold in an $85 million rights offering for 30% of the reorganized K-V's common stock that is open to all of the company's convertible noteholders.
In exchange for the $165 million, the investor group would get 59% percent of K-V's common stock. They ultimately could end up with a total of 89% if they purchase all of the shares sold under the rights offering.
The investor group also is providing the company with an $85 million loan to replace its current bankruptcy financing and a commitment for $100 million in bankruptcy-exit financing.
K-V originally had planned to exit Chapter 11 in the hands of senior noteholders owed more than $225 million, while turning over just 3% of its equity to convertible noteholders owed $200 million. However, objections, primarily from the committee representing K-V's unsecured creditors, delayed that plan, leading to several reschedulings of a hearing that would have allowed that plan to advance to a creditor vote.
As a result of the delays, K-V defaulted on its $85 million bankruptcy financing from Silver Point Finance, which gave K-V until May 10 to pay.
Amid this pressure from its bankruptcy lender, K-V hammered out the terms of the new agreement, which it has been negotiating since December, submitting it to the U.S. Bankruptcy Court in Manhattan on Friday. The new plan would provide greater recoveries to creditors and is likely to garner more creditor support than its original plan, K-V said.
The new plan would provide 6% of K-V's n
K-V Pharmaceutical Co. is pursuing an alternative bankruptcy-exit plan funded by a group of convertible noteholders that has agreed to invest up to $250 million in exchange for majority ownership of the pharmaceutical company. ...
lol jus cover an take ur nickel profit the short was $90+ NOT $72-75 lol you`ll be crushed by fri in the $80
in the end they`ll cover mon.. and move on as FFIV rebounds to the 80 range before 4/24 conf call
whats next $1-.10 this is not an investment for me jus a quick trade
put the damn thing back on the shelves all the risks are clearly spelt out on the label. If it hit the shelves tomorrow 99.% who was on it would be back on it again.